BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3511Biotechnology
$8.89 −$0.18 (-1.98%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $8.96 +0.79%
Open$8.84
Prev close$9.07
Day range$8.80 – $9.46
Volume1.01M
Market cap$577.15M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.3x
CheapRich

Around its usual level · 53rd percentile, 5-year average -2.7x

Price / book2.4x
CheapRich

Near the top of its 5-year range · 87th percentile, 5-year average 1.4x

#3388 of 5329 stocks by PB (1 = cheapest)

Price / sales35.2x
CheapRich

Above its usual level · 61st percentile, 5-year average 35.0x

#4832 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-25x-13x0x13xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$20.85
Price vs. fair value-57.4%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.37 – 1.44 87% (pricier than usual) #3388 of 5329 (1 = cheapest)
PE -3.33 -3.37 -2.73 53% (pricier than usual) –
PS 35.23 27.15 34.98 61% (pricier than usual) #4832 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on CGEM.

Sign in to join the discussion.

Scroll to Top